These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Basic biology and pharmacology of the cardiac sarcolemmal sodium/hydrogen exchanger. Avkiran M J Card Surg; 2003; 18 Suppl 1():3-12. PubMed ID: 12691374 [TBL] [Abstract][Full Text] [Related]
7. Rational basis for use of sodium-hydrogen exchange inhibitors in myocardial ischemia. Avkiran M Am J Cardiol; 1999 May; 83(10A):10G-17G; discussion 17G-18G. PubMed ID: 10482175 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficiency of Na+/Ca2+ exchanger or Na+/H+ exchanger inhibition and their combination in reducing coronary reperfusion-induced arrhythmias. Szepesi J; Acsai K; Sebok Z; Prorok J; Pollesello P; Levijoki J; Papp JG; Varro A; Toth A J Physiol Pharmacol; 2015 Apr; 66(2):215-26. PubMed ID: 25903952 [TBL] [Abstract][Full Text] [Related]
10. Sodium ion/hydrogen ion exchange inhibition: a new pharmacologic approach to myocardial ischemia and reperfusion injury. Levitsky J; Gurell D; Frishman WH J Clin Pharmacol; 1998 Oct; 38(10):887-97. PubMed ID: 9807968 [TBL] [Abstract][Full Text] [Related]
11. Myocardial protection during ventricular fibrillation by inhibition of the sodium-hydrogen exchanger isoform-1. Gazmuri RJ; Ayoub IM; Kolarova JD; Karmazyn M Crit Care Med; 2002 Apr; 30(4 Suppl):S166-71. PubMed ID: 11940795 [TBL] [Abstract][Full Text] [Related]
12. The Na(+)/H(+) exchanger: a target for cardiac therapeutic intervention. Karmazyn M; Sawyer M; Fliegel L Curr Drug Targets Cardiovasc Haematol Disord; 2005 Aug; 5(4):323-35. PubMed ID: 16101565 [TBL] [Abstract][Full Text] [Related]
15. Sodium-hydrogen exchange inhibition during ventricular fibrillation: Beneficial effects on ischemic contracture, action potential duration, reperfusion arrhythmias, myocardial function, and resuscitability. Ayoub IM; Kolarova J; Yi Z; Trevedi A; Deshmukh H; Lubell DL; Franz MR; Maldonado FA; Gazmuri RJ Circulation; 2003 Apr; 107(13):1804-9. PubMed ID: 12665493 [TBL] [Abstract][Full Text] [Related]
16. Regulation of cardiac sarcolemmal Na+/H+ exchanger activity by endogenous ligands. Relevance to ischemia. Avkiran M; Haworth RS Ann N Y Acad Sci; 1999 Jun; 874():335-45. PubMed ID: 10415545 [TBL] [Abstract][Full Text] [Related]
17. Sarcolemmal Na+/H+ exchanger activity and expression in human ventricular myocardium. Yokoyama H; Gunasegaram S; Harding SE; Avkiran M J Am Coll Cardiol; 2000 Aug; 36(2):534-40. PubMed ID: 10933369 [TBL] [Abstract][Full Text] [Related]
18. Modification of intracellular calcium concentration in cardiomyocytes by inhibition of sarcolemmal Na+/H+ exchanger. Saini HK; Dhalla NS Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H2790-800. PubMed ID: 16861694 [TBL] [Abstract][Full Text] [Related]
19. Chronic inhibition of na(+)/h(+)-exchanger in the heart. Baartscheer A Curr Vasc Pharmacol; 2006 Jan; 4(1):23-9. PubMed ID: 16472174 [TBL] [Abstract][Full Text] [Related]
20. Activation of caspase-3 may not contribute to postresuscitation myocardial dysfunction. Radhakrishnan J; Ayoub IM; Gazmuri RJ Am J Physiol Heart Circ Physiol; 2009 Apr; 296(4):H1164-74. PubMed ID: 19234092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]